Supriya Lifescience Limited (SUPRIYA) — Net Asset Momentum
Supriya Lifescience Limited (SUPRIYA) recorded a net asset momentum of 22.2% as of March 2025, with net assets of Rs9.97 Billion INR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check how tangible is Supriya Lifescience Limited's equity to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Supriya Lifescience Limited Net Asset Momentum (2018–2025)
This chart tracks Supriya Lifescience Limited's year-over-year net asset growth across 8 annual reporting periods from 2018 to 2025. The most recent momentum reading is +22.2%, with net assets of Rs9.97 Billion INR as of March 2025. Read SUPRIYA total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Supriya Lifescience Limited (2018–2025)
The table below shows the complete annual net asset history for Supriya Lifescience Limited from 2018 to 2025, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Supriya Lifescience Limited (SUPRIYA) market capitalisation.
| Year | Net Assets (INR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | Rs9.97 Billion | Rs11.12 Billion | Rs1.16 Billion | ▲ +22.2% |
| 2024 | Rs8.15 Billion | Rs9.21 Billion | Rs1.06 Billion | ▲ +16.6% |
| 2023 | Rs6.99 Billion | Rs8.20 Billion | Rs1.21 Billion | ▲ +13.6% |
| 2022 | Rs6.16 Billion | Rs7.35 Billion | Rs1.19 Billion | ▲ +128.9% |
| 2021 | Rs2.69 Billion | Rs4.46 Billion | Rs1.77 Billion | ▲ +80.3% |
| 2020 | Rs1.49 Billion | Rs3.36 Billion | Rs1.87 Billion | ▲ +59.1% |
| 2019 | Rs937.91 Million | Rs2.53 Billion | Rs1.59 Billion | ▲ +71.6% |
| 2018 | Rs546.57 Million | Rs2.45 Billion | Rs1.91 Billion | — |